EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis

Florent Artru iD

United European Gastroenterology Journal · 2025-04 · 13 (3) · 349-350

DOI: 10.1002/ueg2.12640 ↗

Kurz gefasst

Editorial in der Zeitschrift United European Gastroenterology Journal, 2024-11. Verfasst von Florent Artru. Beteiligte Einrichtung: Liver Department, Rennes University Hospital, Rennes, Bretagne, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cirrhosisacute‐on‐chronic liver failurebacterial translocationinflammation

Autor:innen und Institutionen

  • Liver Department, Rennes University Hospital, Rennes, Bretagne, France.
  • NuMeCan Institute, Inserm U1241, Rennes Liver Failure Group (RELIEF), University of Rennes, Rennes, Bretagne, France.

ORCID-Profile: Florent Artru

Zitieren

APA

Artru, F. (2025). Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis. United European Gastroenterology Journal, 13(3), 349-350. https://doi.org/10.1002/ueg2.12640

Vancouver

Artru F. Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis. United European Gastroenterology Journal. 2025;13(3):349-350. doi:10.1002/ueg2.12640

BibTeX
@article{Artru2025,
  author = {Artru, Florent},
  title = {Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {349--350},
  doi = {10.1002/ueg2.12640}
}
Kostenlos starten →